Weiwei Ouyang

Guiyang, 550001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Discovery of a highly selective FLT3-ITD inhibitor with potent antileukemic activity based on 4-(2-fluorophenoxy)pyridine scaffold.

Discovery of a highly selective FLT3-ITD inhibitor with potent antileukemic activity based on 4-(2-fluorophenoxy)pyridine scaffold.

Journal: European journal of medicinal chemistry

Published: July 28, 2026

Comprehensive Proteomic Profiling Reveals Molecular Mechanisms Mediating Chemoradiotherapy Efficacy in Lung Cancer.

Comprehensive Proteomic Profiling Reveals Molecular Mechanisms Mediating Chemoradiotherapy Efficacy in Lung Cancer.

Journal: Journal of proteome research

Published: June 02, 2026

Design, synthesis, and anti-colorectal cancer activity of quinoxalines with improved drug-like properties.

Design, synthesis, and anti-colorectal cancer activity of quinoxalines with improved drug-like properties.

Journal: Bioorganic chemistry

Published: March 03, 2026

Deulorlatinib (TGRX-326) in ALK Gene Fusion Positive NSCLC After Failure of Second-Generation Inhibitors: A Single-Arm, Multicenter, Phase 2 Trial.

Deulorlatinib (TGRX-326) in ALK Gene Fusion Positive NSCLC After Failure of Second-Generation Inhibitors: A Single-Arm, Multicenter, Phase 2 Trial.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: February 09, 2026

An exploratory study on whole-lung radiomics features from computed tomography for prognostic prediction in non-small cell lung cancer with concurrent chemoradiotherapy.

An exploratory study on whole-lung radiomics features from computed tomography for prognostic prediction in non-small cell lung cancer with concurrent chemoradiotherapy.

Journal: Translational cancer research

Published: November 23, 2025

Identification of 2,4-disubstitued pyridine derivatives as potent FMS-like tyrosine receptor kinase 3 (FLT3) inhibitors.

Identification of 2,4-disubstitued pyridine derivatives as potent FMS-like tyrosine receptor kinase 3 (FLT3) inhibitors.

Journal: Bioorganic chemistry

Published: September 28, 2025

MTHFD2 is required for DNA repair and implicated in LUAD radiotherapy resistance.

MTHFD2 is required for DNA repair and implicated in LUAD radiotherapy resistance.

Journal: Journal of translational medicine

Published: September 02, 2025

HMGB1 blockade attenuates cardiac injury induced by radiotherapy combined with PD-1 inhibitor while maintaining the anti-tumor efficacy.

HMGB1 blockade attenuates cardiac injury induced by radiotherapy combined with PD-1 inhibitor while maintaining the anti-tumor efficacy.

Journal: Apoptosis : an international journal on programmed cell death

Published: August 28, 2025

Difference in the inhibitory mechanism against TMPRSS2 between camostat and nafamostat: implications for drug design.

Difference in the inhibitory mechanism against TMPRSS2 between camostat and nafamostat: implications for drug design.

Journal: Physical chemistry chemical physics : PCCP

Published: August 19, 2025

DEP domain containing 1: a potential oncogenic driver.

DEP domain containing 1: a potential oncogenic driver.

Journal: Biological research

Published: July 26, 2025

Case Report: A rare case of ALK-KIF5B gene fusion benefited from treatment with lorlatinib.

Case Report: A rare case of ALK-KIF5B gene fusion benefited from treatment with lorlatinib.

Journal: Frontiers in oncology

Published: March 15, 2025

Relationships of triglyceride-glucose-related indices with colorectal cancer incidence and mortality in an American population: a dose-response meta-analysis and cohort study.

Relationships of triglyceride-glucose-related indices with colorectal cancer incidence and mortality in an American population: a dose-response meta-analysis and cohort study.

Journal: Lipids in health and disease

Published: February 18, 2025

Showing 1-12 of 51

Last Updated: 09/26/2026